Dual Eligibility, Medicare Type Linked To Poststroke Care Quality

When an older adult survives the acute phase of a stroke, the quality of the next stop in their care, whether an inpatient rehabilitation facility (IRF), a skilled nursing facility (SNF), or home health (HH) services, can shape recovery for months and years. New analyses of 44,078 patients show that a person’s Medicare coverage and whether they also qualify for Medicaid (dual eligibility) are linked with meaningful differences in access to higher-rated poststroke care. Specifically, the study found thatdual-eligible and Medicare Advantage (MA) beneficiaries were significantly less likely to receive care from high-quality SNFs and HH agencies compared to those in traditional Fee-for-Service (FFS) Medicare.

Why It Matters

Stroke is a condition where early, coordinated rehabilitation and nursing care materially influence long‑term function, independence, and avoidable complications. Postacute care settings provide different mixes of therapy, nursing oversight, and medical supervision. Getting the right intensity of rehabilitation, in the right place with competent, resourced staff, improves the chances a patient will return home, regain mobility and self‑care, and avoid repeat hospitalizations.

At the same time, the U.S. post-acute care system is fragmented by payment and network rules. Managed Medicare plans often contract with a narrower set of facilities and use utilization controls that can speed placement and limit short‑term costs. Traditional fee‑for‑service Medicare generally gives hospitals and discharge planners a broader set of facility options. Medicare Advantage (MA) plans, which now account for approximately 54% of all Medicare beneficiaries, often use strategies such as narrow provider networks, prior authorization, and cost-sharing to manage utilization. While these strategies aim for efficiency, they can inadvertently result in enrollees facing a limited choice of facilities or being directed toward lower-quality settings.

Key Takeaways from the Data

• The Skilled Nursing Gap: All three comparison groups, (1) FFS Dual, (2) MA Non-dual, and (3) MA Dual, were significantly less likely to be discharged to a high-quality (4- or 5-star) skilled nursing facility compared to the standard FFS non-dual patient.
• Dual Eligibility Impact: Dual-eligible status was a major driver of disparity in nursing home quality, with both FFS and MA dual-eligible patients showing roughly a 43% to 44% lower likelihood (OR 0.57 and 0.56, respectively) of accessing high-quality facilities.
• Home Health Disparities: Medicare Advantage (MA) non-dual-eligible patients faced a significantly lower likelihood (OR 0.71) of accessing high-quality home health agencies compared to the reference group.
• IRF Consistency: No statistically significant associations were found between insurance type or dual status and the quality of inpatient rehabilitation facilities. Researchers noted this may be due to the lack of a standardized star rating system for IRFs compared to SNFs and HH agencies.

Dual Eligible Beneficiaries and Disparities

For patients who are dual eligible, defined as those who rely on both Medicare and Medicaid, the stakes are higher. Dual eligible beneficiaries tend to have more complex medical needs, greater disability after stroke, and fewer private resources to smooth transitions. When coverage design, network size, and care coordination practices interact with a vulnerable patient’s clinical needs, disparities in the quality of poststroke care can emerge. The study revealed that dual-eligible MA beneficiaries had the lowest estimated probability (0.41) of being discharged to a high-quality SNF, whereas non-dual FFS beneficiaries had the highest probability (0.58).

These disparities matter beyond individual recovery. Differences in where patients go after hospital discharge affect readmission rates, long‑term functional recovery, caregiver burden, and downstream healthcare spending. Regions with concentrated managed‑care markets can see systematic patterns in which facilities receive referrals of MA beneficiaries. Hospitals tied to particular networks may default to in‑network placements that are not necessarily the highest quality locally. In short, coverage type and dual‑eligibility status are not neutral administrative labels. In actuality, they influence real decisions at a sensitive moment, with consequences for patients and healthsystems alike.

Who It Affects

Patients recovering from stroke are the most directly affected, especially those with significant disability who need structured rehabilitation and skilled nursing care. Dual‑eligible beneficiaries, who are often poorer, older, and with a higher burden of chronic illness, face compounded risk. This patient population is more likely to require intensive post-acute services, but is less likely to be funneled to top‑rated facilities under some coverage arrangements.

Discharge Disposition

In this study’s cohort, 39.4% were discharged to IRFs, 36.9% to SNFs, and 23.8% to HH care. Dual‑eligible beneficiaries, who now constitute more than 50% of MA enrollees, face “doubled challenges” due to higher clinical severity and restricted access to top-tier facilities.

The demographic breakdown of these groups highlights further socioeconomic intersections:

• Dual-eligible FFS patients were more likely to be non-Hispanic Black (21.7%) or Hispanic (12.7%) compared to their non-dual FFS counterparts.
• Dual-eligible MA patients had even higher proportions of minority representation, with 32.8% identifying as non-Hispanic Black and 15.6% as Hispanic.

Challenges of Discharge Planning

Hospitals and discharge planners also feel the impact. Clinicians must balance clinical judgment about the intensity of rehabilitation needed with real‑world constraints such as plan networks, prior authorization requirements, and bed availability. This creates ethical and operational tensions at the bedside: the clinical team wants the best place for recovery, while administrative and payer rules may limit those options or delay placement. MA plans may exert tighter control to reduce costs, sometimes incentivizing the use of SNFs that save money despite delivering lower-quality care.

Payers and Policymakers

Payers and policymakers are critical stakeholders as well. Medicare program administrators, state Medicaid programs, and managed‑care organizations make design choices that affect network adequacy, benefit design, and quality oversight. The research suggests that as MA and dual enrollment grow, the design of value-based post-acute care is a priority to ensure high-need patients maximize gains from therapy. Private nursing homes, rehabilitation operators, and home health agencies experience the financial and reputational implications of referral patterns. High volumes of managed‑care patients can change a facility’s financial model and staffing choices.

Caregivers and Family Members

For caregivers and family members, the burden is heavy. Thestudy notes that improving awareness of facility quality ratings among caregivers is essential to reducing these systemic disparities. Finally, caregivers and family members are often left to navigate complex information about facility quality during an already stressful time, and their capacity to advocate varies widely across socio‑economic groups.

What Changes

The study’s findings point toward several necessary shifts in policy and practice:

• Refining Discharge Planning: Hospitals must weigh coverage limits against clinical needs. The research found that MA enrollees were significantly less likely to reach high-quality SNFs (OR 0.82) and high-quality HH agencies (OR 0.71) compared to FFS enrollees. Clinicians should document functional goals, such as those measured by the Section GG tools for self-care and mobility, to justify placements in higher-quality facilities.
• Transparency in Quality Reporting: While SNFs and HH agencies use a 5-star rating system, IRFs currently lack a standardized composite star rating, relying instead on measures like potentially preventable readmissions. Establishing consistent, easy-to-understand metrics across all post-acute care settings is vital.
• Network Adequacy Standards: Payers using narrow networks should be held to stricter standards. If an MA plan’s network consists primarily of lower-rated facilities, enrollees are systematically disadvantaged. Interestingly, the study found that a high number of MA plans in a geographic area actually increased the likelihood of high-quality SNF discharge (OR 1.45), suggesting that market competition can improve provider networks.
• Addressing Geographic and Supply Factors: Access is often tied to local supply. For instance, a high concentration of SNFs in a region was associated with a lower likelihood of accessing high-quality HH care (OR 0.56), indicating a “substitution effect” where patients may be funneled into institutional care even when home-based care might be preferable.

Looking ahead, several practical moves can nudge the system toward more equitable poststroke recovery. Hospitals can ensure care managers have real‑time access to facility performance profiles. Plans can establish expedited pathways when clinical need is documented. States and federal overseers can strengthen rules for beneficiaries who are dually eligible, ensuring that “equitable access to high-value post-acute care is essential to advancing outcomes for high-need, high-risk patients”.

Methodological Context and Limitations

To understand these findings, it is helpful to look at the study’s rigorous design. Researchers used a 20% random sample of Medicare data from 2021 to 2022. They risk-adjusted for various factors, including the Charlson Comorbidity Index, NIH Stroke Scale (NIHSS), and acute hospital length of stay.

However, some limitations exist:

• The study could not distinguish between patients receiving no post-acute care and those using outpatient services (Medicare Part B).
• There was a lack of direct long-term health outcomes (like mortality or 90-day functional gain) specifically tied to the high- vs. low-quality facility access.
• The IRF quality measure (preventable readmissions) may have lacked the sensitivity of the more established 5-star systems used for SNFs and HH agencies, which might explain why no significant quality differences were found for IRFs.

Conclusion

Ultimately, equitable poststroke recovery depends on aligning clinical needs with transparent quality information and plan incentives. As the population of dual-eligible and MA beneficiaries continues to grow, addressing the intersection of insurance type and facility quality is not just an administrative challenge, but a clinical and ethical necessity.

Improving measures

Improvements in measurement would also help. Some post-acute settings have well‑known composite ratings; others lack standardized public metrics that capture outcomes important after stroke, such as functional gains or within‑stay preventable readmissions. Better, consistently reported measures across all post-acute settings would allow clinicians, patients, and policymakers to track where gaps persist and to align incentives for quality improvement.

Real-World Challenges

Operational realities complicate change. Many markets face workforce shortages in nursing, therapy, and specialized rehabilitation clinicians. Remedying access inequities requires investment in staffing, training, and retention. Rural areas may have few high‑quality facilities nearby, so solutions there must include transportation support, tele‑rehabilitation models, and mobile or visiting therapy teams. Financial trade‑offs are real: narrower networks can deliver savings for plans and lower premiums for enrollees, but those savings should not come at the cost of worse recovery or higher long‑term disability.

For clinicians and discharge teams, concrete steps include documenting functional objectives that justify a higher‑intensity placement, engaging social workers and community‑based organizations early, and ensuring patients and families receive clear explanations of what different post-acute settings offer. For policymakers, the priority is to ensure that coverage design and market incentives align with clinical best practices for stroke recovery and do not disproportionately penalize those with the fewest resources.

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC12933277/